{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:22:36Z","timestamp":1762111356239,"version":"3.44.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.biopsych.2020.07.025","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T09:20:36Z","timestamp":1605086436000},"page":"e41-e42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Brain Amyloid Deposition in Late-Life Depression"],"prefix":"10.1016","volume":"89","author":[{"given":"Nunzio","family":"Pomara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0327-7262","authenticated-orcid":false,"given":"Bruno Pietro","family":"Imbimbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2020.07.025_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.biopsych.2020.06.017","article-title":"Late-life depression is associated with reduced cortical amyloid burden: Findings from the Alzheimer\u2019s Disease Neuroimaging Initiative Depression Project","volume":"89","author":"Mackin","year":"2021","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2020.07.025_bib2","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1073\/pnas.0914141107","article-title":"Increased fibrillar amyloid-\u03b2 burden in normal individuals with a family history of late-onset Alzheimer\u2019s","volume":"107","author":"Mosconi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2020.07.025_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jpsychires.2018.10.008","article-title":"Cortical thickness, brain metabolic activity, and in\u00a0vivo amyloid deposition in asymptomatic, middle-aged offspring of patients with late-onset Alzheimer\u2019s disease","volume":"107","author":"Duarte-Abritta","year":"2018","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.biopsych.2020.07.025_bib4","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/archneurol.2011.3029","article-title":"Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging","volume":"69","author":"Whitwell","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2020.07.025_bib5","doi-asserted-by":"crossref","first-page":"e1094","DOI":"10.1038\/tp.2017.49","article-title":"Assessing the presence of shared genetic architecture between Alzheimer\u2019s disease and major depressive disorder using genome-wide association data","volume":"7","author":"Gibson","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2020.07.025_bib6","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJM199511093331902","article-title":"Apolipoprotein E, dementia, and cortical deposition of \u03b2-amyloid protein","volume":"333","author":"Polvikoski","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biopsych.2020.07.025_bib7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1176\/appi.ajp.2011.11081153","article-title":"Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder","volume":"169","author":"Pomara","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2020.07.025_bib8","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/WNR.0000000000000658","article-title":"State-dependent alterations in cerebrospinal fluid A\u03b242 levels in cognitively intact elderly with late-life major depression","volume":"27","author":"Pomara","year":"2016","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopsych.2020.07.025_bib9","first-page":"1417","article-title":"A\u00a0retrospective evaluation of PET scanner properties utilizing brain Hoffman phantom imaging for F-18-AV-45 study","volume":"51","author":"Saha","year":"2010","journal-title":"J\u00a0Nucl Med"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632232031948X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632232031948X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:08:50Z","timestamp":1757776130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000632232031948X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S000632232031948X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2020.07.025","relation":{},"ISSN":["0006-3223"],"issn-type":[{"type":"print","value":"0006-3223"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain Amyloid Deposition in Late-Life Depression","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2020.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2020.06.017","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}